Yawu Liu Selected Research

welan (S 130)

5/2019

Maximum lesions area and orthogonal values accessed from DWI images would be alternative imaging markers for predicting the outcome of acute ischemia in the middle cerebral artery territory.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yawu Liu Research Topics

Disease

7	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2010
7	Cognitive Dysfunction 01/2021 - 01/2010
5	Dementia (Dementias) 01/2021 - 01/2017
3	Atrophy 01/2020 - 01/2013
3	Stroke (Strokes) 01/2020 - 11/2002
2	Ischemic Stroke 01/2021 - 11/2002
2	Infarction (Infarctions) 01/2020 - 05/2019
2	Cytomegalovirus Infections (Inclusion Disease) 01/2010 - 08/2006
2	Infections 01/2010 - 08/2006
1	Epilepsy (Aura) 01/2022
1	Focal Cortical Dysplasia 01/2022
1	Partial Epilepsies (Epilepsy, Partial) 01/2022
1	Glioma (Gliomas) 01/2021
1	Frontotemporal Dementia (Semantic Dementia) 01/2020
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Neurobehavioral Manifestations 01/2020
1	Liver Neoplasms (Liver Cancer) 05/2019
1	Hepatocellular Carcinoma (Hepatoma) 05/2019
1	Schizophrenia (Dementia Praecox) 05/2015
1	Memory Disorders (Memory Loss) 01/2013
1	Ischemia 04/2008
1	Hemostatic Disorders 01/2008
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 02/2007
1	Aneurysm (Aneurysms) 02/2007

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2013
5	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2017
5	Apolipoproteins E (ApoE)IBA 01/2020 - 11/2002
3	Pemetrexed (MTA)FDA Link 01/2020 - 01/2013
3	ApolipoproteinsIBA 01/2010 - 11/2002
1	Pharmaceutical PreparationsIBA 01/2022
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2021
1	GadoliniumIBA 01/2021
1	welan (S 130)IBA 05/2019
1	Carcinoembryonic AntigenIBA 05/2019
1	Proteins (Proteins, Gene)FDA Link 05/2019
1	Antipsychotic Agents (Antipsychotics)IBA 05/2015
1	pleiotrophin (HARP)IBA 02/2015
1	Antiviral Agents (Antivirals)IBA 01/2010
1	Ganciclovir (Cytovene)FDA LinkGeneric 01/2010
1	Indicators and Reagents (Reagents)IBA 04/2008
1	Hemostatics (Antihemorrhagics)IBA 01/2008
1	N 30IBA 02/2007
1	Fas Ligand Protein (Fas Ligand)IBA 08/2006
1	Fumigant 93 (D-D)IBA 07/2006

Therapy/Procedure

3	Liver Transplantation 01/2010 - 08/2006
1	Precision Medicine 01/2022
1	Therapeutics 01/2020
1	Cognitive Training 01/2019
1	Aftercare (After-Treatment) 02/2007